107 related articles for article (PubMed ID: 4017172)
1. Agglutination by concanavalin A of urothelial cells of heterotropically transplanted rat urinary bladders: effect of bladder carcinogens and urine.
Homma Y; Ozono S; Wallenmark CB; Oyasu R
Carcinogenesis; 1985 Jul; 6(7):1059-61. PubMed ID: 4017172
[TBL] [Abstract][Full Text] [Related]
2. Concanavalin A agglutination of bladder cells of rats treated with bladder carcinogens; a rapid new test to detect bladder carcinogens.
Kakizoe T; Kawachi T; Okada M
Cancer Lett; 1978 Nov; 5(5):285-90. PubMed ID: 728886
[TBL] [Abstract][Full Text] [Related]
3. The effect of disulfiram on the carcinogenicity of N-butyl-N-(3-carboxypropyl)nitrosamine in the rat.
Irving CC; Daniel DS; Murphy WM
Carcinogenesis; 1983; 4(5):617-20. PubMed ID: 6850994
[TBL] [Abstract][Full Text] [Related]
4. Increased agglutinability of bladder cells by concanavalin A after administration of carcinogens.
Kakizoe T; Komatsu H; Niijima T; Kawachi T; Sugimura T
Cancer Res; 1980 Jun; 40(6):2006-9. PubMed ID: 7371036
[TBL] [Abstract][Full Text] [Related]
5. Focal suppression and induction of hyperplasia by the bladder carcinogens butyl(4-hydroxybutyl)nitrosamine and buty(3-carboxypropyl)nitrosamine in organ-cultured rat bladder epithelium.
Reese DH; Friedman RD; Gaffield W; Keefer LK
J Natl Cancer Inst; 1978 Jan; 60(1):219-23. PubMed ID: 628018
[TBL] [Abstract][Full Text] [Related]
6. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
Suzuki E; Okada M
Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630
[TBL] [Abstract][Full Text] [Related]
7. Agglutination of bladder cells by concanavalin A during the early phase of treatment of rats with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kakizoe T; Kawachi T; Sugimura T
Cancer Res; 1979 Sep; 39(9):3353-6. PubMed ID: 476666
[TBL] [Abstract][Full Text] [Related]
8. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Suzuki E; Mochizuki M; Okada M
Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of urinary bladder tumorigenesis by carcinogen-exposed stroma.
Uchida K; Samma S; Momose H; Kashihara N; Rademaker A; Oyasu R
J Urol; 1990 Mar; 143(3):618-21. PubMed ID: 2304182
[TBL] [Abstract][Full Text] [Related]
10. Induction of tumors in heterotopic bladder by topical application of N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl)nitrosamine.
Oyasu R; Iwasaki T; Matsumoto M; Hirao Y; Tabuchi Y
Cancer Res; 1978 Sep; 38(9):3019-25. PubMed ID: 679209
[TBL] [Abstract][Full Text] [Related]
11. Agglutination assay of bladder cells by Concanavalin A proved the high susceptibility of analbuminemic rats to bladder carcinogens.
Honma Y; Kakizoe T; Komatsu H; Niijima T; Sugimura T; Nagase S
Cancer Lett; 1983 May; 19(1):7-11. PubMed ID: 6850570
[TBL] [Abstract][Full Text] [Related]
12. Investigations on organ-specific metabolism and genotoxic effects of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine (BCPN) and its analogs N-nitrosodibutylamine (NDBA) and N-nitrosobutyl-4-hydroxybutylamine (4-OH-NDBA).
Janzowski C; Jacob D; Henn I; Zankl H; Poole-Zobel BL; Eisenbrand G
Toxicology; 1989 Dec; 59(2):195-209. PubMed ID: 2588266
[TBL] [Abstract][Full Text] [Related]
13. Induction of repair synthesis of DNA in primary cultures of rat urothelial cells by derivatives of the bladder carcinogen, N-n-butyl-N-(4-hydroxybutyl)nitrosamine.
Wang CY; Zukowski K; Daniel DS; Irving CC
Chem Biol Interact; 1985; 53(1-2):99-105. PubMed ID: 3995657
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism of bladder carcinogenic nitrosamines by rat liver and urothelial cells.
Airoldi L; Magagnotti C; De Gregorio G; Moret M; Fanelli R
Chem Biol Interact; 1992 Apr; 82(2):231-40. PubMed ID: 1568272
[TBL] [Abstract][Full Text] [Related]
15. Rapid assay of N-butyl-N-(3-carboxypropyl)nitrosamine in rat organs and urine by high-performance liquid chromatography after derivatization.
Wada S; Funae Y; Imaoka S; Kawamura M; Kinoshita Y; Sugimoto T; Nishio S; Kishimoto T; Maekawa M
Jpn J Cancer Res; 1985 Mar; 76(3):192-6. PubMed ID: 3922837
[TBL] [Abstract][Full Text] [Related]
16. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
Suzuki E; Anjo T; Aoki J; Okada M
Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
[TBL] [Abstract][Full Text] [Related]
17. Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53+/- knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Mori Y; Koide A; Fuwa K; Wanibuchi H; Fukushima S
Mutagenesis; 2001 Sep; 16(5):377-83. PubMed ID: 11507236
[TBL] [Abstract][Full Text] [Related]
18. The heterotopically transplanted rat urinary bladder as a model for detection of tumor-promoting urinary growth factor(s).
Oyasu R; Konno S; Stevens J; Hayashi O
Toxicol Pathol; 1986; 14(3):331-4. PubMed ID: 3787115
[TBL] [Abstract][Full Text] [Related]
19. Influence of disulfiram on the metabolism of the urinary bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
Irving CC; Daniel DS
Carcinogenesis; 1987 Sep; 8(9):1309-15. PubMed ID: 3113755
[TBL] [Abstract][Full Text] [Related]
20. Involvement of urine in epithelial-stromal interactions in urinary bladder carcinogenesis.
Momose H; Uchida K; Kakinuma H; Yura Y; Oyasu R
Cancer Lett; 1990 Sep; 53(2-3):91-6. PubMed ID: 2208083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
